2. |
BP measured at least in 2 occasions
prior to commencement of drug therapy |
|
90% |
|
110 |
(31.5%) |
|
16 |
(4.6%) |
|
223 (63.9%) |
/ |
|
% of cases if unknown cases excluded
|
|
|
|
|
87.3% |
|
|
12.7% |
|
|
|
3. |
Symptoms and signs of target organ damage
assessed: |
|
90% |
|
|
|
|
|
|
|
|
|
|
b. |
left ventricular hypertrophy |
|
|
|
69 |
(19.8%) |
|
280 |
(80.2%) |
|
/ |
/ |
|
f. |
peripheral vascular disease |
|
|
|
26 |
(7.4%) |
|
323 |
(92.6%) |
|
/ |
/ |
4. |
Risk factors for cardiovascular and
cerebrovascular disease assessed |
|
90% |
|
|
|
|
|
|
|
|
|
|
g. |
family history of coronary artery disease |
|
|
|
343 |
(98.3%) |
|
6 |
(1.7%) |
|
/ |
/ |
5. |
Pre-treatment BP > 140/90 |
|
90% |
|
125 |
(35.8%) |
|
1 |
(0.3%) |
|
223 (63.9%) |
/ |
|
% of cases if unknown cases excluded
|
|
|
|
|
99.2% |
|
|
0.8% |
|
|
|
6. |
Patient reviewed at least every 6 months
|
|
90% |
|
344 |
(98.2%) |
|
5 |
(1.4%) |
|
/ |
/ |
|
b. |
Blood pressure <130/80 for patients with diabetes
or renal disease |
|
|
|
17 |
(20%) |
|
67 |
(80%) |
|
/ |
/ |
8. |
Patient referred for specialist advice |
|
90% |
|
4 |
(1.1%) |
|
3 |
(0.9%) |
|
/ |
342 (98%) |
|
% if cases not indicated excluded |
|
|
|
|
57.1% |
|
|
42.9% |
|
|
|
9. |
Side effects of drugs assessed annually |
|
80% |
|
275 |
(78.8%) |
|
74 |
(11.2%) |
|
/ |
/ |
10. |
Diet advice given annually |
|
80% |
|
237 |
(67.9%) |
|
112 |
(22.1%) |
|
/ |
/ |